{
  "docId": "019de076-05a8-756d-90c0-05335f3877b6",
  "docSlug": "06c66508aa113b26851e16e612e1d04c",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 28,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "other",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "AA = Advanced Adenoma; CRC = Colorectal Cancer. Data sourced from JNCI 2022.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/12",
  "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6",
  "deckJsonHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6.json",
  "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.6,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "list",
      "text": "If a screening tests in 45yr olds and above resulted in: 21% sensitivity for AA: Reduction of CRC incidence by 30%; Reduction of CRC mortality by 47%. 76% sensitivity for AA: Reduction in CRC incidence by 57%; Reduction in CRC mortality by 67%.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08510a64-f3ae-4fa1-b54a-9e4d49ccf90e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Discussion of CMS decision memo on thresholds of 74% sensitivity, 90% specificity for blood-based screening for CRC. No thresholds set for detection of AA.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45b94413-eab4-4542-a6dc-78e5d9e24217",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.81
      },
      "kind": "source-note",
      "text": "Ladabaum U, et al. Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity, JNCI: Journal of the National Cancer Institute, Volume 114, Issue 7, July 2022, Pages 1040-1043",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9ce739d-b14f-4ab3-b7a6-91a396c33361",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "title",
      "text": "Including AAs detection in screening tests significantly reduces both incidence and mortality",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "739b9f24-5cad-4abc-8543-e2da600e4a96",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Impact of AA sensitivity on CRC Mortality and Incidents Rates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23fc9755-773c-4a4b-a7ac-8db851787ded",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "3275461b-fbc7-42b7-8160-bc4083977f4b",
      "evidence": "Discussion of CMS decision memo on thresholds of 74% sensitivity, 90% specificity for blood-based screening for CRC. No thresholds set for detection of AA.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 12,
      "from": 11,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "65c6d63c-5d6a-4a99-909a-65517b4e456c",
      "evidence": "The document presents a problem statement and highlights the benefits of early detection",
      "position": 0,
      "objective": "To highlight the importance of early CRC detection and the consequences of inaction",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}